← Back to Search

Active Seating System for Healthy Lifestyle in Older Adults

N/A
Waitlist Available
Led By Stacey L Schepens Niemiec, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intervention-present monitoring period (3-7days) relative to pre-intervention 72-hour baseline
Awards & highlights

Study Summary

This trial aims to develop an innovative device to help older adults reduce immobile time and improve their health. Its features include a posture chair, exercise machine, rehabilitation tool and activity tracker.

Who is the study for?
This trial is for English-speaking older adults, aged 65 or above, living in the Los Angeles area. Participants should be able to do light exercises daily and pedal comfortably for 5 minutes. It's not suitable for those who can't transfer to a chair safely, have unstable health conditions like uncontrolled blood pressure, or are undergoing certain treatments like chemotherapy.Check my eligibility
What is being tested?
The FitSitt device is being tested; it's designed to help older adults reduce sitting time by integrating physical activity into their daily routine at home. The study will assess user acceptability and how well FitSitt encourages more active behavior.See study design
What are the potential side effects?
Since this intervention involves physical activity using a specialized chair (FitSitt), potential side effects may include muscle soreness or discomfort from new exercise routines. However, specific side effects will depend on individual experiences with the device.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intervention-present monitoring period (3-7days) relative to pre-intervention 72-hour baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and intervention-present monitoring period (3-7days) relative to pre-intervention 72-hour baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Daily Prolonged Sedentary Bouts (activPAL+FitSitt sensors) change from baseline to up to 7 days with intervention present
Secondary outcome measures
Daily Steps change from baseline to up to 7 days with intervention present
FitSitt Pedaling Usage Behavior
FitSitt Seat Occupancy Usage Behavior
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: In-home feasibility testExperimental Treatment1 Intervention
In this single-arm trial, participants will use an active seating system for a 3- to 7-day period. The system provides a seating platform and treadles to pedal while in a seated or semi-reclined position. The system will also include a digital user interface to track performance.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FitSitt Prototype
2023
N/A
~20

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,672 Previous Clinical Trials
28,018,646 Total Patients Enrolled
University of Southern CaliforniaLead Sponsor
906 Previous Clinical Trials
1,596,271 Total Patients Enrolled
Stacey L Schepens Niemiec, PhDPrincipal InvestigatorUniversity of Southern California Chan Division of OS-OT

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants can this clinical trial accommodate at its peak?

"Correct. Records on clinicaltrials.gov demonstrate that this scientific study, which was initially published on September 27th 2023, is actively searching for participants. Approximately 15 patients need to be sourced from 1 centre of medical care."

Answered by AI

Is this experiment still open for participant recruitment?

"Affirmative. The clinical trial page hosted on the website confirms that enrollment is ongoing - it was initially uploaded to the site on September 27th 2023 and updated as recently as October 5th 2023. Currently, 15 participants are required for this single-site medical study."

Answered by AI

Who else is applying?

What site did they apply to?
University of Southern California
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Active Seating System to Lessen Sedentariness in Older Adults: In-home Testing Phase
Stacey L. Schepens Niemiec 2023. "Active Seating System to Lessen Sedentariness in Older Adults: In-home Testing Phase". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05510297.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top